|
Name |
Styrene
|
Molecular Formula | C8H8 | |
IUPAC Name* |
styrene
|
|
SMILES |
C=CC1=CC=CC=C1
|
|
InChI |
InChI=1S/C8H8/c1-2-8-6-4-3-5-7-8/h2-7H,1H2
|
|
InChIKey |
PPBRXRYQALVLMV-UHFFFAOYSA-N
|
|
Synonyms |
STYRENE; Ethenylbenzene; Vinylbenzene; Phenylethylene; 100-42-5; Styrol; Benzene, ethenyl-; Cinnamene; Phenylethene; Styrolene; Styrene monomer; Phenethylene; Vinylbenzol; Vinyl benzene; 9003-53-6; Styropol SO; Styrole; Styren; Benzene, vinyl-; Ethylene, phenyl-; Cinnamenol; Cinnamol; Vinylbenzen; Stirolo; Styreen; Vinyl-benzene; Bulstren K-525-19; Annamene; Styrol [German]; NCI-C02200; Cinnaminol; FEMA No. 3233; NSC 62785; CHEBI:27452; Styrol (German); 44LJ2U959V; MFCD00084450; NSC-62785; 12770-88-6; Diarex hf 77; NCGC00091056-01; DSSTox_CID_1284; Styreen [Dutch]; Styren [Czech]; Styrene, analytical standard; DSSTox_RID_76057; DSSTox_GSID_21284; Stirolo [Italian]; 25086-18-4; Benzene-d5, ethenyl-d3-; Vinylbenzen [Czech]; Vinylbenzen [Dutch]; Styron; FEMA Number 3234; Styrene 100 microg/mL in Methanol; MFCD00008612; Styrene (monomer); CAS-100-42-5; CCRIS 564; HSDB 171; Vinylbenzene, inhibited; Phenylethylene, inhibited; EINECS 202-851-5; UN2055; Styrene monomer, inhibited; ethenyl-benzene; phenyl-ethylene; UNII-44LJ2U959V; p-vinyl benzene; AI3-24374; Styron (Salt/Mix); Ethenylbenzene, 9CI; trans-Styrene-[d2]; Styropol (Salt/Mix); Styropor (Salt/Mix); MAOMIN SM; PhCH=CH2; STYRENE [HSDB]; STYRENE [IARC]; STYRENE [INCI]; Styrene, >=99%; STYRENE [MI]; EC 202-851-5; Diarex hf 77 (Salt/Mix); Styrene-(phenyl-[13C6]); UN 2055 (Salt/Mix); WLN: 1U1R; BIDD:ER0247; Styrene Resin (Med.M.Wt.); CHEMBL285235; DTXSID2021284; ZINC968269; NSC62785; TTB 7302; Styrene, ReagentPlus(R), 99.9%; Tox21_113245; Tox21_200808; STL283958; Styrene 2000 microg/mL in Methanol; Styrene 5000 microg/mL in Methanol; AKOS000119972; ZINC112958499; Styrene, SAJ first grade, >=99.0%; NCGC00091056-02; NCGC00091056-03; NCGC00091056-04; NCGC00091056-05; NCGC00258362-01; BP-13451; FT-0659991; FT-0674668; FT-0674669; FT-0674670; FT-0689054; S0651; COLESTYRAMINE IMPURITY A [EP IMPURITY]; EN300-19671; C07083; C19506; Q28917; A800199; Styrene, 99.5% stab. with 4-tert-Butylcatechol; Styrene contains 4-tert-Butylcatechol as stabilizer; F1908-0130; Z104474664; Styrene monomer, inhibited [UN2055] [Flammable liquid]; Styrene, ReagentPlus(R), contains 4-tert-butylcatechol as stabilizer, >=99%
|
|
CAS | 9003-53-6 | |
PubChem CID | 7501 | |
ChEMBL ID | CHEMBL285235 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 104.15 | ALogp: | 2.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.513 |
Caco-2 Permeability: | -4.319 | MDCK Permeability: | 0.00002550 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.298 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.929 | Plasma Protein Binding (PPB): | 79.77% |
Volume Distribution (VD): | 2.776 | Fu: | 15.15% |
CYP1A2-inhibitor: | 0.93 | CYP1A2-substrate: | 0.385 |
CYP2C19-inhibitor: | 0.166 | CYP2C19-substrate: | 0.656 |
CYP2C9-inhibitor: | 0.087 | CYP2C9-substrate: | 0.608 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.498 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.257 |
Clearance (CL): | 10.208 | Half-life (T1/2): | 0.694 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.131 |
Drug-inuced Liver Injury (DILI): | 0.454 | AMES Toxicity: | 0.189 |
Rat Oral Acute Toxicity: | 0.046 | Maximum Recommended Daily Dose: | 0.043 |
Skin Sensitization: | 0.827 | Carcinogencity: | 0.491 |
Eye Corrosion: | 0.979 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.164 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000012 | 0.643 | D01ZJK | 0.500 | ||||
ENC000023 | 0.529 | D05OIS | 0.438 | ||||
ENC001615 | 0.529 | D0X9RY | 0.412 | ||||
ENC001091 | 0.500 | D05BMG | 0.378 | ||||
ENC001736 | 0.500 | D0H0HJ | 0.378 | ||||
ENC000052 | 0.483 | D0T3LF | 0.378 | ||||
ENC000064 | 0.483 | D0P9AC | 0.368 | ||||
ENC000408 | 0.455 | D0U0RZ | 0.359 | ||||
ENC000759 | 0.447 | D0P6UB | 0.350 | ||||
ENC000053 | 0.441 | D0LG8E | 0.333 |